abstract |
The invention relates to the use of a hydroxystilbene-containing active ingredient or a hydroxystilbene-containing active ingredient combination selected from resveratrol and piceatannol precursors or functional derivatives thereof; and their stereoisomeric forms, in each case in the form of their salts or in the phenol form, for the preparation of an agent for the prevention and / or treatment of diseases whose formation and / or course is accompanied by an elevated serum IL-6 level and / or their formation and / or course by administration of a selective estrogen receptor ß (ER-ß) agonist is treatable. |